GSK Case Study: A $3 Billion Settlement
GlaxoSmithKline (GSK), a leading pharmaceutical company, came under intense scrutiny for engaging in unlawful practices that raised significant concerns about patient safety, corporate ethics, and regulatory compliance. Allegations against the company ranged from misleading drug promotion to failure to report safety data and false price reporting. These accusations prompted an extensive investigation, culminating in a […]